Terray Therapeutics powers forward, with our announcement of the NVIDIA strategic investment. KdT Ventures continues to believe that without high quality scaled data, ML/AI does not work in science. Very few have a <real> dataset as dense and scalable as Terray- though many pitch they do, substituting in silico data (trained on what?) to pull a fast one on naive investors. Proud to have continued our participation since the seed round in a company we believe will seismically change the landscape of small molecule development.
Today is a big day for Terray. We’re excited to announce a collaboration and investment from NVentures, NVIDIA’s Venture Capital arm, to realize the promise of our new molecular language for #generativeAI in small molecule drug discovery. We believe that true change for small molecule discovery and development won’t happen in a vacuum—it will happen when the right companies strategically align to push the industry forward. Read the press release here: https://lnkd.in/gQC774Rm #drugdiscovery #AI #smallmolecules #nvidia #biotech
